A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE | MicrobiomeTrials

← Back to trials

NCT06897930

A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2025-04-21Est. Completion: 2029-05-01

Enrollment target: 150 participants

Locations

Research Site, San Francisco, California, United States
Research Site, Stanford, California, United States
Research Site, Tampa, Florida, United States
Research Site, Atlanta, Georgia, United States
Research Site, Chicago, Illinois, United States
Research Site, Baltimore, Maryland, United States
Research Site, Bethesda, Maryland, United States
Research Site, Boston, Massachusetts, United States
Research Site, St Louis, Missouri, United States
Research Site, New York, New York, United States
Research Site, Syracuse, New York, United States
Research Site, Chapel Hill, North Carolina, United States
Research Site, Charlotte, North Carolina, United States
Research Site, Richmond, Virginia, United States
Research Site, Seattle, Washington, United States
Research Site, Seattle, Washington, United States
Research Site, Darlinghurst, Australia
Research Site, Melbourne, Australia

Other microbiome trials you might be interested in

Epidemiological Study of Treatment Approaches in AChR-Antibody Positive Generalized Myasthenia Gravis in RussiaRecruiting

Rare DiseasesGeneralized Myasthenia Gravis (gMG)

This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describ…

Kazan', RussiaEst. completion Dec 31, 2029

An Extension Study to Learn More About the Long-Term Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus ErythematosusPhase 3ENROLLING_BY_INVITATION

Systemic Lupus Erythematosus (SLE)

In this study, researchers will learn more about a study drug called litifilimab (BIIB059) in participants with systemic…

Phoenix, United StatesCompleted Mar 29, 2030

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.